Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study.

Cox DG, Penney K, Guo Q, Hankinson SE, Hunter DJ.

BMC Cancer. 2007 Sep 11;7:175.

2.

Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.

Kaklamani VG, Baddi L, Liu J, Rosman D, Phukan S, Bradley C, Hegarty C, McDaniel B, Rademaker A, Oddoux C, Ostrer H, Michel LS, Huang H, Chen Y, Ahsan H, Offit K, Pasche B.

Cancer Res. 2005 Apr 15;65(8):3454-61. Erratum in: Cancer Res. 2006 Mar 15;66(6):3345.

3.

TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis.

Castillejo A, Rothman N, Murta-Nascimento C, Malats N, García-Closas M, Gómez-Martínez A, Lloreta J, Tardón A, Serra C, García-Closas R, Chanock S, Silverman DT, Dosemeci M, Kogevinas M, Carrato A, Soto JL, Real FX.

Int J Cancer. 2009 Feb 1;124(3):608-13. doi: 10.1002/ijc.24013.

4.

Genetic Polymorphisms of TGFB1, TGFBR1, SNAI1 and TWIST1 Are Associated with Endometrial Cancer Susceptibility in Chinese Han Women.

Yang L, Wang YJ, Zheng LY, Jia YM, Chen YL, Chen L, Liu DG, Li XH, Guo HY, Sun YL, Tian XX, Fang WG.

PLoS One. 2016 May 12;11(5):e0155270. doi: 10.1371/journal.pone.0155270. eCollection 2016.

5.

Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.

Försti A, Li X, Wagner K, Tavelin B, Enquist K, Palmqvist R, Altieri A, Hallmans G, Hemminki K, Lenner P.

Genes Chromosomes Cancer. 2010 Mar;49(3):270-81. doi: 10.1002/gcc.20738.

PMID:
19998449
6.

TGFBR1 polymorphism and risk of breast cancer in Iranian women.

Kamali E, Hemmati S, Safari F, Tavassoli M.

Int J Biol Markers. 2015 Nov 11;30(4):e414-7. doi: 10.5301/jbm.5000102.

PMID:
26165686
7.

Role of polymorphisms in Adamantiades-Behçet's disease.

Kaklamani VG, Sadim M, Koumantaki Y, Kaklamanis P, Pasche B.

J Rheumatol. 2008 Dec;35(12):2376-8. Epub 2008 Oct 15.

8.

TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.

Song B, Margolin S, Skoglund J, Zhou X, Rantala J, Picelli S, Werelius B, Lindblom A.

Br J Cancer. 2007 Oct 22;97(8):1175-9. Epub 2007 Sep 11.

10.

[Correlations of polymorphisms of TGFB1 and TGFBR2 genes to genetic susceptibility to gastric cancer].

Zhou Y, Jin GF, Jiang GJ, Wang HM, Tan YF, Ding WL, Wang LN, Chen WS, Ke Q, Shen J, Xu YC, Shen HB.

Ai Zheng. 2007 Jun;26(6):581-5. Chinese.

PMID:
17562261
11.

Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies.

Wang YQ, Qi XW, Wang F, Jiang J, Guo QN.

PLoS One. 2012;7(8):e42899. doi: 10.1371/journal.pone.0042899. Epub 2012 Aug 8. Review.

12.

VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix.

Soufla G, Sifakis S, Baritaki S, Zafiropoulos A, Koumantakis E, Spandidos DA.

Cancer Lett. 2005 Apr 18;221(1):105-18.

PMID:
15797633
13.

The transforming growth factor-β receptor genes and the risk of intracranial aneurysms.

Ruigrok YM, Baas AF, Medic J, Wijmenga C, Rinkel GJ.

Int J Stroke. 2012 Dec;7(8):645-8. doi: 10.1111/j.1747-4949.2011.00615.x. Epub 2011 Oct 6.

PMID:
21978186
14.

Somatic acquisition and signaling of TGFBR1*6A in cancer.

Pasche B, Knobloch TJ, Bian Y, Liu J, Phukan S, Rosman D, Kaklamani V, Baddi L, Siddiqui FS, Frankel W, Prior TW, Schuller DE, Agrawal A, Lang J, Dolan ME, Vokes EE, Lane WS, Huang CC, Caldes T, Di Cristofano A, Hampel H, Nilsson I, von Heijne G, Fodde R, Murty VV, de la Chapelle A, Weghorst CM.

JAMA. 2005 Oct 5;294(13):1634-46.

PMID:
16204663
15.

Transforming growth factor β signaling pathway associated gene polymorphisms may explain lower breast cancer risk in western Indian women.

Joshi NN, Kale MD, Hake SS, Kannan S.

PLoS One. 2011;6(8):e21866. doi: 10.1371/journal.pone.0021866. Epub 2011 Aug 4.

16.

The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk.

Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Bahadori B, Samonigg H.

Cancer Lett. 2003 Nov 25;201(2):181-4.

PMID:
14607332
17.

The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.

Colleran G, McInerney N, Rowan A, Barclay E, Jones AM, Curran C, Miller N, Kerin M, Tomlinson I, Sawyer E.

Breast Cancer Res Treat. 2010 Jan;119(2):437-42. doi: 10.1007/s10549-009-0395-0. Epub 2009 Apr 24. Erratum in: Breast Cancer Res Treat. 2012 Jan;131(2);727.

PMID:
19390964
18.

Involvement of transforming growth factor β and its type 1 receptor in the development of breast cancer.

Keshelava VV, Khodorovich OS, Shaykhaev GO, Chazova NL, Bereschanskaya AM.

Bull Exp Biol Med. 2011 Nov;152(1):98-100. English, Russian.

PMID:
22803051
19.

Association of single nucleotide polymorphisms in the genes ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema after breast conserving radiotherapy.

Raabe A, Derda K, Reuther S, Szymczak S, Borgmann K, Hoeller U, Ziegler A, Petersen C, Dikomey E.

Radiat Oncol. 2012 Apr 26;7:65. doi: 10.1186/1748-717X-7-65.

20.

Concordant promoter methylation of transforming growth factor-beta receptor types I and II occurs early in esophageal squamous cell carcinoma.

Dong Z, Guo W, Guo Y, Kuang G, Yang Z.

Am J Med Sci. 2012 May;343(5):375-81. doi: 10.1097/MAJ.0b013e3182253430.

PMID:
22314103

Supplemental Content

Support Center